Healthequity Valuation
| 2HE Stock | EUR 90.50 1.50 1.69% |
At this time, the firm appears to be undervalued. Healthequity retains a regular Real Value of €103.4 per share. The prevalent price of the firm is €90.5. Our model calculates the value of Healthequity from evaluating the firm fundamentals such as return on equity of -0.0313, and Return On Asset of 0.0037 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Healthequity's price fluctuation is very steady at this time. Calculation of the real value of Healthequity is based on 3 months time horizon. Increasing Healthequity's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Healthequity stock is determined by what a typical buyer is willing to pay for full or partial control of Healthequity. Since Healthequity is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Healthequity Stock. However, Healthequity's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 90.5 | Real 103.4 | Hype 90.5 | Naive 91.44 |
The real value of Healthequity Stock, also known as its intrinsic value, is the underlying worth of Healthequity Company, which is reflected in its stock price. It is based on Healthequity's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Healthequity's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Healthequity helps investors to forecast how Healthequity stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Healthequity more accurately as focusing exclusively on Healthequity's fundamentals will not take into account other important factors: Healthequity Total Value Analysis
Healthequity is presently estimated to have takeover price of 5.61 B with market capitalization of 5.19 B, debt of 922.08 M, and cash on hands of 329.31 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Healthequity fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.61 B | 5.19 B | 922.08 M | 329.31 M |
Healthequity Investor Information
About 98.0% of the company shares are owned by institutions such as pension funds. The book value of Healthequity was presently reported as 22.25. The company has Price/Earnings To Growth (PEG) ratio of 1.91. Healthequity recorded a loss per share of 0.66. The entity had not issued any dividends in recent years. Based on the key measurements obtained from Healthequity's financial statements, Healthequity is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Healthequity Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Healthequity implies not a very effective usage of assets in December.Healthequity Ownership Allocation
Healthequity secures a total of 84.64 Million outstanding shares. The majority of Healthequity outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Healthequity to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Healthequity. Please pay attention to any change in the institutional holdings of Healthequity as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.Healthequity Profitability Analysis
The company reported the revenue of 756.56 M. Net Loss for the year was (44.29 M) with profit before overhead, payroll, taxes, and interest of 423.71 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Healthequity's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Healthequity and how it compares across the competition.
About Healthequity Valuation
The stock valuation mechanism determines Healthequity's current worth on a weekly basis. Our valuation model uses a comparative analysis of Healthequity. We calculate exposure to Healthequity's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Healthequity's related companies.HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. HealthEquity, Inc. was founded in 2002 and is headquartered in Draper, Utah. HealthEquity operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1141 people.
8 Steps to conduct Healthequity's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Healthequity's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Healthequity's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Healthequity's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Healthequity's revenue streams: Identify Healthequity's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Healthequity's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Healthequity's growth potential: Evaluate Healthequity's management, business model, and growth potential.
- Determine Healthequity's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Healthequity's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Healthequity Stock analysis
When running Healthequity's price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |